Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
16.53
-0.31 (-1.84%)
At close: Jun 6, 2025, 4:00 PM
16.70
+0.17 (1.03%)
After-hours: Jun 6, 2025, 7:41 PM EDT
Cellebrite DI Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for Cellebrite DI stock ranges from a low of $17 to a high of $26. The average analyst price target of $22.43 forecasts a 35.69% increase in the stock price over the next year.
Price Target: $22.43 (+35.69%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cellebrite DI stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 7 | 7 | 6 | 6 | 6 | 6 |
Buy | 2 | 2 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9 | 9 | 7 | 7 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +45.19% | Jun 6, 2025 |
Needham | Needham | Strong Buy Maintains $28 → $24 | Strong Buy | Maintains | $28 → $24 | +45.19% | May 14, 2025 |
JP Morgan | JP Morgan | Buy Maintains $29 → $25 | Buy | Maintains | $29 → $25 | +51.24% | May 12, 2025 |
Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +69.39% | Apr 2, 2025 |
Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +69.39% | Mar 27, 2025 |
Financial Forecast
Revenue This Year
484.45M
from 401.20M
Increased by 20.75%
Revenue Next Year
568.34M
from 484.45M
Increased by 17.32%
EPS This Year
0.47
from -1.35
EPS Next Year
0.52
from 0.47
Increased by 10.09%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 502.9M | 596.4M | 709.8M | |
Avg | 484.5M | 568.3M | 667.6M | |
Low | 460.6M | 535.6M | 610.2M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 25.3% | 23.1% | 24.9% | |
Avg | 20.7% | 17.3% | 17.5% | |
Low | 14.8% | 10.6% | 7.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 0.53 | 0.59 | 0.71 | |
Avg | 0.47 | 0.52 | 0.63 | |
Low | 0.39 | 0.43 | 0.54 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | - | 25.6% | 38.6% | |
Avg | - | 10.1% | 21.7% | |
Low | - | -8.7% | 4.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.